Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market
Holding ENSC?
Track your performance easily

Ensysce Biosciences (ENSC) Financial Statements

224 Followers

Ensysce Biosciences Financial Overview

Ensysce Biosciences's market cap is currently ―. The company's EPS TTM is $-2.755; its P/E ratio is -0.19; Ensysce Biosciences is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 181.80K$ 305.72K$ 515.03K$ 435.38K$ 490.47K
Gross Profit$ 181.80K$ 305.72K$ 515.03K$ 435.38K$ 490.47K
EBIT$ -1.97M$ 2.42M$ -3.16M$ -2.68M$ -2.24M
EBITDA$ -1.94M$ 3.59M$ -3.16M$ -2.68M$ -2.24M
Net Income Common Stockholders$ -1.97M$ -3.12M$ -3.50M$ -2.69M$ -2.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.04M$ 3.40M$ 1.12M$ 1.46M$ 3.83M
Total Assets$ 2.80M$ 5.07M$ 2.71M$ 3.22M$ 6.36M
Total Debt$ 454.46K$ 245.97K$ 854.70K$ 353.66K$ 456.66K
Net Debt$ -588.77K$ -3.16M$ -268.91K$ -1.11M$ -3.37M
Total Liabilities$ 1.32M$ 1.65M$ 3.36M$ 2.06M$ 2.56M
Stockholders Equity$ 1.81M$ 3.75M$ -322.86K$ 1.49M$ 4.08M
Cash Flow-
Free Cash Flow$ -2.31M$ -3.41M$ -1.80M$ -2.26M$ -3.11M
Operating Cash Flow$ -2.31M$ -3.41M$ -1.80M$ -2.26M$ -3.11M
Investing Cash Flow-----
Financing Cash Flow$ -51.23K$ 5.69M$ 1.46M$ -102.45K$ 5.52M
Currency in USD

Ensysce Biosciences Earnings and Revenue History

Ensysce Biosciences Debt to Assets

Ensysce Biosciences Cash Flow

Ensysce Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis